Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 1
2005 4
2006 1
2007 8
2008 7
2009 6
2010 6
2011 4
2012 6
2013 6
2014 3
2015 8
2016 9
2017 11
2018 10
2019 7
2020 18
2021 15
2022 7
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Results by year

Filters applied: . Clear all
Page 1
NOVEOS and ImmunoCAP Have Similar Performances for Diagnosing Food Allergies.
Trouche-Estival B, Vitte J, Martin-Blondel A, Michelet M, Gruzelle V, Didier A, Guilleminault L, Mailhol C, Rivera SM, De Lima Correia A, Taurus C, Blancher A, Goret J, Klingebiel C, Apoil PA. Trouche-Estival B, et al. Among authors: didier a. J Allergy Clin Immunol Pract. 2024 Mar 6:S2213-2198(24)00262-9. doi: 10.1016/j.jaip.2024.02.037. Online ahead of print. J Allergy Clin Immunol Pract. 2024. PMID: 38458433 Free article.
The economic burden of asthma prior to death: a nationwide descriptive study.
Guilleminault L, Mounié M, Sommet A, Camus C, Didier A, Reber LL, Conte C, Costa N. Guilleminault L, et al. Among authors: didier a. Front Public Health. 2024 Feb 19;12:1191788. doi: 10.3389/fpubh.2024.1191788. eCollection 2024. Front Public Health. 2024. PMID: 38439749 Free PMC article.
Improvement in severe asthma patients receiving biologics and factors associated with persistent insufficient control: a real-life national study.
Guilleminault L, Camus C, Raherison-Semjen C, Capdepon A, Bourdin A, Bonniaud P, Fry S, Devouassoux G, Blanc FX, Pison C, Dupin C, Khayath N, Courdeau J, Valcke-Brossollet J, Nocent-Ejnaini C, Rolland F, Lamandi C, Proust A, Ozier A, Portel L, Gaspard W, Roux-Claude P, Beurnier A, Martinez S, Dot JM, Hennegrave F, Vignal G, Auvray E, Paleiron N, Just N, Miltgen J, Russier M, Olivier C, Taillé C, Didier A. Guilleminault L, et al. Among authors: didier a. Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231202749. doi: 10.1177/17534666231202749. Ther Adv Respir Dis. 2023. PMID: 37966015 Free PMC article.
Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy.
Louis R, Harrison TW, Chanez P, Menzella F, Philteos G, Cosio BG, Lugogo NL, de Luiz G, Burden A, Adlington T, Keeling N, Kwiatek J, Garcia Gil E; ANDHI Study Investigators. Louis R, et al. J Allergy Clin Immunol Pract. 2023 Jun;11(6):1759-1770.e7. doi: 10.1016/j.jaip.2023.03.009. Epub 2023 Mar 21. J Allergy Clin Immunol Pract. 2023. PMID: 36948488 Free article.
Reply to Gille and collaborators: DM and VC impairment after COVID-1.
Elise NS, Marion D, Grégoire P, Julien M, Alain D. Elise NS, et al. Among authors: alain d. Respir Med Res. 2023 Jun;83:100956. doi: 10.1016/j.resmer.2022.100956. Epub 2022 Sep 28. Respir Med Res. 2023. PMID: 36563554 No abstract available.
Updated guidelines (2021) for management and follow-up of asthmatic patients of the French Society of Pneumology (SPLF) and the French Society of Pediatric Pneumology and Allergology (SP2A). Short version.
Raherison-Semjen C, Guilleminault L, Billiart I, Chenivesse C, De Oliveira A, Izadifar A, Lorenzo A, Nocent C, Oster JP, Padovani M, Perez T, Russier M, Steinecker M, Didier A. Raherison-Semjen C, et al. Among authors: didier a. Respir Med Res. 2022 May;81:100898. doi: 10.1016/j.resmer.2022.100898. Epub 2022 May 5. Respir Med Res. 2022. PMID: 35526320
123 results